CD274 and nonpapillary renal cell carcinoma: Although ccRCC tumors are molecularly and immunologically heterogeneous, the focus of this minireview is to identify additional biomarkers altered in ccRCC other than VEGF and PD-L1 that can be effectively downregulated by nontoxic doses of selenium.